eupolicy.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
This Mastodon server is a friendly and respectful discussion space for people working in areas related to EU policy. When you request to create an account, please tell us something about you.

Server stats:

238
active users

We're kicking off now, watch HERE: privacycamp.eu/

Are you ready to ⚡️ reveal, rethink and change the systems ⚡️ ?

✅ digital systems of exclusion
✅ & patients' rights
✅ is big business
✅ extractivist solutions for the

Share your thoughts with us in this thread!

Jan Penfrat

Looking forward to a deep-dive discussion at comparing regimes in the and and how (and if at all) they protect ' rights.

#EHDS#NHS#privacy

Of course clinical researcher Teodora Lalova-Spinks makes clear from the start that primary and secondary use of medical records under the proposed is not the same regarding .

Interesting how in , only very few patients actually use their opt-out right for secondary medical data use.

Reasons according to Nicola Hamilton on the panel: People don't know about their right. And defaults matter.

A consent requirement for secondary use in the would have been so much fairer. 🤷

Hm, Benoit Marchal from the Association claims that when 10-20% of people were to opt out of secondary use of medical data, the other 80% would become useless because those opt-outers were "the most interesting data".

Really not sure why this would be the case. 🧐

European parliament advisor Francesco Vogelezang points at all the safeguards the parliament position on the has introduced.

Okay agreed, but you'll need to bring those through the in one piece and I think EU member states want to :dumpster_fire: it all down.

Despite some gaps and unanswered questions this was a really interesting panel on the , big thanks to @bisilisib for the moderation!

Next up: is Big Business: How instrumentalises to expand its infrastructural power. :trashfire:

Featuring @KrisShrishak, @Thijmen_vg, Donald Bertulfo, and @carmelatroncoso, moderated by the one and only @Seda Gürses :)

speakers @KrisShrishak and @ThijmenStar show easily how transparently corporations like and use their products to increase their infrastructural power and take over entire markets. 😵

It's really wow to hear Dr @carmelatroncoso, who worked on the contact tracing protocol in 2020, tell how and used their power over their mobile OS to make life hard for those building the protocol and the actual apps.

She's citing take-it-or-leave-it kind of power, in particular through design and unilateral changes to it.

Excellent argument made by @carmelatroncoso at :

is not about protecting your data, it's about protecting *you* from effects and actions you'd rather avoid. It's a means to a very important end.

@ilumium Amazingly enough we're three speakers in and several elephants in the room remain unmentioned:

* medical secrecy law as a body of law separate from data protection law
* data quality and semantics remaining an unsolved problem and tied closely to regulation of medical healthcare and not data protection law

This panel appears to have swallowed the argument this is solely a data protection issue. It is not.